Google快讯 - disease

	disease 实时更新 ⋅ 2019年10月1日
	新闻
	FDA OKs Canagliflozin to Curtail Diabetic Kidney Disease Medscape The US Food and Drug Administration (FDA) has approved canagliflozin (Invokana, Janssen) to reduce the risk of end-stage kidney disease, ... 标记为不相关
	Canagliflozin Approved for Renal Disease, Cardiovascular Events in T2D MD Magazine Canagliflozin Approved for Renal Disease, Cardiovascular Events in T2D ... in patients with both type 2 diabetes and chronic kidney disease (CKD). 标记为不相关
	EXCEL at 5 Years: PCI, CABG 'Relatively Comparable' for Left Main Coronary Disease Medscape "PCI may thus be considered an acceptable revascularization modality for selected patients with left main disease, a decision which should be made ... 标记为不相关
查看更多结果 | 修改此快讯

您收到此电子邮件是因为您订阅了Google快讯。 退订 | 查看您所有的快讯

以RSS Feed的形式接收此快讯

发送反馈